Commonwealth Equity Services LLC Buys 2,512 Shares of Ulta Beauty Inc (NASDAQ:ULTA)

Share on StockTwits

Commonwealth Equity Services LLC lifted its stake in shares of Ulta Beauty Inc (NASDAQ:ULTA) by 36.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,395 shares of the specialty retailer’s stock after acquiring an additional 2,512 shares during the quarter. Commonwealth Equity Services LLC’s holdings in Ulta Beauty were worth $2,355,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently modified their holdings of the company. Bell & Brown Wealth Advisors LLC acquired a new stake in Ulta Beauty during the third quarter worth approximately $2,871,000. L & S Advisors Inc grew its stake in Ulta Beauty by 26.0% during the second quarter. L & S Advisors Inc now owns 2,588 shares of the specialty retailer’s stock worth $898,000 after purchasing an additional 534 shares during the period. AMP Capital Investors Ltd grew its stake in Ulta Beauty by 40.6% during the second quarter. AMP Capital Investors Ltd now owns 43,014 shares of the specialty retailer’s stock worth $14,807,000 after purchasing an additional 12,417 shares during the period. BlackRock Inc. grew its stake in Ulta Beauty by 5.3% during the second quarter. BlackRock Inc. now owns 4,166,032 shares of the specialty retailer’s stock worth $1,445,154,000 after purchasing an additional 207,927 shares during the period. Finally, FTB Advisors Inc. grew its stake in Ulta Beauty by 396.2% during the second quarter. FTB Advisors Inc. now owns 129 shares of the specialty retailer’s stock worth $44,000 after purchasing an additional 103 shares during the period. Institutional investors own 87.39% of the company’s stock.

ULTA has been the subject of several recent analyst reports. UBS Group decreased their target price on Ulta Beauty from $365.00 to $300.00 and set a “buy” rating for the company in a research note on Friday, August 30th. Wolfe Research initiated coverage on Ulta Beauty in a research note on Tuesday, October 8th. They set a “buy” rating and a $288.00 target price for the company. Oppenheimer decreased their target price on Ulta Beauty from $390.00 to $310.00 and set an “outperform” rating for the company in a research note on Friday, August 30th. William Blair cut Ulta Beauty to a “buy” rating in a research note on Friday, August 30th. Finally, Atlantic Securities cut Ulta Beauty from an “overweight” rating to a “neutral” rating and reduced their price objective for the company from $390.00 to $250.00 in a research note on Friday, August 30th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and thirteen have given a buy rating to the company. Ulta Beauty presently has an average rating of “Hold” and a consensus price target of $290.95.

In other news, CEO Mary N. Dillon bought 1,300 shares of the stock in a transaction on Thursday, September 26th. The shares were purchased at an average cost of $237.17 per share, for a total transaction of $308,321.00. Following the completion of the purchase, the chief executive officer now directly owns 79,256 shares in the company, valued at approximately $18,797,145.52. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Charles Heilbronn bought 70,009 shares of the stock in a transaction on Monday, September 30th. The stock was purchased at an average price of $248.66 per share, for a total transaction of $17,408,437.94. Following the completion of the purchase, the director now owns 60,368 shares of the company’s stock, valued at $15,011,106.88. The disclosure for this purchase can be found here. Over the last 90 days, insiders acquired 186,567 shares of company stock worth $44,964,903. Corporate insiders own 4.20% of the company’s stock.

Shares of ULTA opened at $239.29 on Monday. The firm has a market cap of $14.44 billion, a PE ratio of 22.05, a PEG ratio of 1.24 and a beta of 1.13. The stock’s fifty day moving average price is $242.23 and its two-hundred day moving average price is $307.03. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.80 and a quick ratio of 0.57. Ulta Beauty Inc has a 1 year low of $224.43 and a 1 year high of $368.83.

Ulta Beauty (NASDAQ:ULTA) last issued its earnings results on Thursday, August 29th. The specialty retailer reported $2.76 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $2.79 by ($0.03). The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.68 billion. Ulta Beauty had a net margin of 9.86% and a return on equity of 37.04%. The business’s quarterly revenue was up 12.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.46 earnings per share. Sell-side analysts anticipate that Ulta Beauty Inc will post 11.81 earnings per share for the current fiscal year.

About Ulta Beauty

Ulta Beauty, Inc operates as a beauty retailer in the United States. The company's stores offer cosmetics, fragrances, skincare and haircare products, bath and body products, and salon styling tools; salon services, including hair, skin, makeup, and brow services; and others, including nail products and accessories.

Featured Story: What is the yield curve?

Want to see what other hedge funds are holding ULTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ulta Beauty Inc (NASDAQ:ULTA).

Institutional Ownership by Quarter for Ulta Beauty (NASDAQ:ULTA)

Receive News & Ratings for Ulta Beauty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ulta Beauty and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Goldman Sachs Group Reiterates “€36.30” Price Target for Deutsche Wohnen
Goldman Sachs Group Reiterates “€36.30” Price Target for Deutsche Wohnen
Orchard Funding Group  Receives Buy Rating from Liberum Capital
Orchard Funding Group Receives Buy Rating from Liberum Capital
Aviat Networks  Lowered to “Hold” at ValuEngine
Aviat Networks Lowered to “Hold” at ValuEngine
Jefferies Financial Group Reaffirms “Buy” Rating for B&M European Value Retail
Jefferies Financial Group Reaffirms “Buy” Rating for B&M European Value Retail
Zumiez Inc.  to Post FY2022 Earnings of $2.24 Per Share, Wedbush Forecasts
Zumiez Inc. to Post FY2022 Earnings of $2.24 Per Share, Wedbush Forecasts
Pacira Biosciences  vs. Vanda Pharmaceuticals  Critical Review
Pacira Biosciences vs. Vanda Pharmaceuticals Critical Review


© 2006-2019 Ticker Report